Company: CERO
Filing Date: 2025-11-19
Form Type: 10-Q
Source: 0001213900-25-112619
Chunk: 189

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-11-19
Form: 10-Q
Item: Item 8
Chunk 189
---
 shall be reduced to the Series D New Issuance Price.

19

If 30 days or 60 days
following the occurrence of the later of (x) the Series D Stockholder Approval Date and (y) the earlier of (a) the
effective date of the registration statement to be filed pursuant to the Registration Rights Agreement and (b) the date that the
Series D Preferred Stock is eligible to be resold without restriction under Rule 144 of the Securities Act, the Series D
Conversion Price then in effect is the greater of $3.12 and the Market Price (as defined in the Series D Certificate of Designations)
then in effect (the “Series D Adjustment Price”), the Conversion Price shall automatically lower to the Series D
Adjustment Price.

On August 13, 2025, the Company
and the Investors of Series D Preferred Stock entered into an Amendment and Limited Waiver Agreement (the “Waiver Agreement”),
whereby the Investors (i) amended the Registration Rights Agreement to extend certain deadlines therein and (ii) waive certain provisions
of the Series D COD. Pursuant to the Waiver Agreement, the Company and the Series D Preferred Holders acknowledged that it was inefficient
and impracticable to file the Registration Statement prior to the consummation of additional closings. Accordingly, the filing deadline
with respect to the initial Registration Statement was extended to August 15, 2025; The Registration Statement on Form S-3 was filed on
August 11, 2025. Additionally, the “Effectiveness Deadline” with respect to the initial Registration Statement required to
be filed, shall be the earlier of the (A) October 15, 2025 (or, if such Registration Statement is subject to a full review by the SEC,
November 30, 2025 and (B) fifth Business Day after the date the Company is notified (orally or in writing, whichever is earlier) by the
SEC that such Registration Statement will not be reviewed or will not be subject to further review and (ii) with respect to any additional
Registration Statements that may be required to be filed by the Company pursuant to this Waiver Agreement, the earlier of the (A) ninetieth
(90th) calendar day following the date on which the Company was required to file such additional Registration Statement and (B) fifth
(5th) Business Day after the date the Company is notified (